A Risk Stratification Model for Low Stage Uterine leiomyosarcoma

ModPath Chat
07/07/2022 17 min
A Risk Stratification Model for Low Stage Uterine leiomyosarcoma

Listen "A Risk Stratification Model for Low Stage Uterine leiomyosarcoma"

Descargar episodio

Episode Synopsis


Uterine leiomyosarcoma is the most common uterine mesenchymal malignancy. The majority present at stage I with variable clinical outcome.In this episode of ModPath Chat, Dr. David Chapel discusses his recently published multi-institutional study proposing a novel risk stratification model (shown below) for low stage uterine leiomyosarcoma.Risk score = (coagulative necrosis)(1) + (mitoses > 25 per 2.4mm2)(2) + (atypical mitoses)(2) + (lymphovascular invasion)(3) + (serosal abutment)(5)

More episodes of the podcast ModPath Chat

Invasive Lobular Carcinoma (ILC): European Lobular Breast Cancer Consortium Recommendations. Anne Vincent-Salomon and Maxim De Schepper 31/12/2024
Fumarate hydratase deficient renal cell carcinoma. Guido Martignoni and Anna Caliò 06/12/2024
Intraductal oncocytic papillary neoplasm, Claudio Luchini and Gaetano Paolini 18/11/2024
Gastrointestinal Langerhans cell histiocytosis: New insights. Shaomin Hu and Yue Xue 28/10/2024
Opening the Black Box: Spatial Transcriptomics and the Relevance of Artificial Intelligence–Detected Prognostic Regions in High-Grade Serous Carcinoma. Anna Ray Laury et al 10/10/2024
Pathologist-Driven Reflex Somatic Tumor DDR Testing in Localized Prostate Cancer. Susan Prendeville and Shamini Selvarajah 09/09/2024
Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman 21/08/2024
A Portrait of HER2- Low Invasive Lobular Carcinoma (ILC) of Breast. Lounes Djerroudi Anne Vincent-Salomon 02/08/2024
Special Episode - Meet the Listeners 14/06/2024
Molecular Profiling of Sinonasal Olfactory Carcinoma with Lisa Rooper, MD 31/05/2024
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA